The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:

Grisaru et al. (1) reported antimanic effects from rapid transcranial magnetic stimulation of the right prefrontal cortex. In a 14-day double-blind trial, right and left prefrontal stimulations were compared in patients receiving repeated rapid transcranial magnetic stimulation in addition to antimanic drug therapy. We report here on a patient with euphoric mania that was refractory to treatment with sulthiame (2) who experienced marked improvement during monotherapy with right prefrontal rapid transcranial magnetic stimulation.

Ms. A was a 59-year-old woman with a diagnosis of bipolar I disorder. After her first and only depressive episode, which developed postpartum at age 35, she experienced at least four severe manic episodes. Eight weeks before hospital admission she developed euphoric mania despite lithium treatment. Lithium treatment was discontinued, and a trial with the antiepileptic drug sulthiame was initiated—unfortunately, with no effect after 3 weeks of treatment. Sulthiame treatment was tapered off, and monotherapy with rapid transcranial magnetic stimulation was begun. Right prefrontal stimulation was performed, as suggested by Grisaru et al. (1): 20 trains per session, a frequency of 20 Hz for 2 seconds per train, and an intertrain interval of 1 minute.

Ms. A was given five consecutive sessions during weeks 1 and 2 and three sessions during weeks 3 and 4. Her range of motor threshold was 66%–76%. Her scores on the Bech-Rafaelsen Mania Scale (3) slowly but continuously fell (28 on day 0, 24 on day 7, 15 on day 14, 10 on day 21, and 8 on day 28). Her sleep disturbance and thought disorder seemed to respond particularly well to rapid transcranial magnetic stimulation. Ms. A was dismissed from the hospital ward. Prophylactic treatment with the third-generation, putative mood-stabilizing anticonvulsant topiramate (4) was initiated for Ms. A for obesity.

Although new strategies in the treatment of acute mania are clearly needed (5), Grisaru et al.’s observation (1) that add-on treatment with right prefrontal rapid transcranial magnetic stimulation is effective in treating mania (showing laterality opposite to the proposed effect of rapid transcranial magnetic stimulation in depression) deserves particular interest. In this case, repeated monotherapy with right prefrontal rapid transcranial magnetic stimulation was effective and well tolerated in a patient with euphoric mania. Further systematic studies are needed.

References

1. Grisaru N, Chudakov B, Yaroslavsky Y, Belmaker RH: Transcranial magnetic stimulation in mania: a controlled study. Am J Psychiatry 1998; 155:1608–1610Google Scholar

2. Bennie EH, Allen HB: Sulthiame in the management of psychiatric patients. Br J Psychiatry 1976; 128:511–512Crossref, MedlineGoogle Scholar

3. Bech P, Rafaelsen OJ, Kramp P, Bolwig TG: The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 1978; 17:430–431Crossref, MedlineGoogle Scholar

4. Post RM, Denicoff KD, Frye MA, Dunn RT, Leverich GS, Osuch E, Speer A: A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century. Neuropsychobiology 1998; 38:152–166Crossref, MedlineGoogle Scholar

5. Erfurth A, Grunze H: New perspectives in the treatment of acute mania. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22:1053–1059Google Scholar